Diagnostic model development for schizophrenia based on peripheral blood mononuclear cell subtype-specific expression of metabolic markers

HIGHLIGHTS

• who: Jihan K. Zaki from the Study population Samples and data analysed in the present study were collected as part of the clinical trial of simvastatin supplementation in schizophrenia (ClinicalTrialsgov identifier: , [17, ]). The study population consisted of , participants between , and , years old diagnosed with schizophrenia spectrum disorder using the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) [19] guidelines. Only patients with recent-onset psychosis were enroled, and therefore the maximum duration of psychosis at the start of the trial was , years. The trial was conducted at the University Medical Center Utrecht (UMCU) and . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.